A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

NCT06214481 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen